As a memorial tribute to an extraordinary woman, Krav Maga Worldwide™ and STOP CANCER created The Marni Fund, with a shared mission dedicated to developing improved treatments, new diagnostic procedures and the ultimate goal – a cure. Created in memory of Marni Levine (1969–2006), The Marni Fund is currently supporting innovative Breast Cancer researchers at UCLA, USC and City of Hope NCI-designated Comprehensive Cancer Centers.
Today, we introduce you to one of those researchers: Dr. Melanie Palomares.
Dr. Melanie Palomares is Assistant Professor of Population Sciences and Medical Oncology, Co-Director of the Risk Breast Clinic, and Staff Physician of Clinical Cancer Genetics.
Since joining City of Hope in 2003, with the help of the Marni Levine Memorial Research Award, she has used her multidisciplinary training in oncology, epidemiology, and genetics to develop a translational research program for both patients who are at increased risk for cancer (primary cancer prevention and screening) and cancer survivors (secondary cancer prevention and surveillance).
Translational clinical trials in cancer prevention require the development and validation of biomarkers of cancer risk and modification of that risk. She has studied mammographic density as a radiographic marker of breast cancer risk. She is also investigating several molecular markers of breast cancer diagnosis and prognosis, comparing multiple DNA, RNA, proteomic, and whole cell based methodologies. With accurate risk prediction, she will be able to target the most appropriate people for cancer prevention strategies in the future.